| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 09/06/2008 | 20:31 | Edgar (US Regulatory) | Nastech Pharmaceutical CO Inc - Prospectus filed pursuant to Rule 424(b)(5) (424B5) | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 09/06/2008 | 13:00 | Business Wire | Nastech Announces Positive Intranasal Insulin Data at American Diabetes Association Meeting | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 15/05/2008 | 00:55 | Edgar (US Regulatory) | Nastech Pharmaceutical CO Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 08/05/2008 | 22:05 | Edgar (US Regulatory) | Nastech Pharmaceutical CO Inc - Quarterly Report (10-Q) | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 08/05/2008 | 22:03 | Edgar (US Regulatory) | Nastech Pharmaceutical CO Inc - Current report filing (8-K) | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 08/05/2008 | 22:00 | Business Wire | Nastech Announces First Quarter 2008 Financial Results | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 01/05/2008 | 22:00 | Business Wire | Nastech to Release First Quarter Financial Results and Host Webcast on Thursday, May 8, 2008 | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 29/04/2008 | 19:50 | Edgar (US Regulatory) | Nastech Pharmaceutical CO Inc - Proxy Statement (definitive) (DEF 14A) | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 25/04/2008 | 14:00 | Business Wire | Nastech Pharmaceutical Company Inc. Raises $7.93 Million in Registered Direct Offering | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 18/04/2008 | 12:04 | Edgar (US Regulatory) | Nastech Pharmaceutical CO Inc - Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A) | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 27/03/2008 | 13:00 | Business Wire | Nastech Pharmaceutical Company Inc. Announces Appointment of Gunter Blobel, M.D., Ph.D., to its MDRNA, Inc. Scientific Advisory | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 25/03/2008 | 17:41 | Business Wire | Nastech Pharmaceutical Company Inc. to Present RNAi Data | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 21/03/2008 | 21:00 | Business Wire | Nastech Pharmaceutical Company Inc. Complies with Nasdaq Marketplace Rule 4350(b)(1)(B) | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 19/03/2008 | 02:36 | Business Wire | Wall Street Media Presents a Video of Dr. Gordon Brandt, President of Nastech Pharmaceutical Company (NASDAQGM: NSTK) | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 17/03/2008 | 21:09 | Edgar (US Regulatory) | Nastech Pharmaceutical CO Inc - Annual Report (10-K) | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 17/03/2008 | 21:00 | Business Wire | Nastech Announces Fourth Quarter and Full Year 2007 Financial Results | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 13/03/2008 | 13:00 | Business Wire | Nastech Pharmaceutical Company Inc. to Present at the Invest Northwest CEO & Investor Forum | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 11/03/2008 | 13:00 | Business Wire | Nastech Pharmaceutical Company Inc. Completes Key RNAi Patent Filings | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 07/03/2008 | 14:00 | Business Wire | Nastech Pharmaceutical Company Inc. Announces Scientific Advisory Board for MDRNA, Inc., its Wholly-Owned RNAi Subsidiary | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 29/02/2008 | 20:23 | PR Newswire (US) | Nastech Pharmaceutical Company Inc. to Hold Conference Call to Discuss Corporate Restructuring and Future Strategy on Monday, Ma | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 12/02/2008 | 20:05 | PR Newswire (US) | Nastech Pharmaceutical Company Implements Additional Workforce Reduction as Part of Previously Announced Corporate Restructuring | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 08/02/2008 | 19:40 | Edgar (US Regulatory) | Nastech Pharmaceutical CO Inc - Amended Statement of Ownership (SC 13G/A) | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 05/02/2008 | 23:30 | Edgar (US Regulatory) | Nastech Pharmaceutical CO Inc - Statement of Ownership (SC 13G) | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 05/02/2008 | 14:00 | PR Newswire (US) | Nastech Appoints MDRNA, Inc. Directors Strategic Advisory Board | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 05/02/2008 | 12:00 | Edgar (US Regulatory) | Nastech Pharmaceutical CO Inc - Notice of Effectiveness (EFFECT) | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 22/01/2008 | 15:11 | Edgar (US Regulatory) | Nastech Pharmaceutical CO Inc - Securities Registration Statement (simplified form) (S-3) | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 08/01/2008 | 14:00 | PR Newswire (US) | Nastech Completes Enrollment of Phase 2 Clinical Trial of PYY3-36 Nasal Spray to Treat Obesity | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 08/01/2008 | 13:30 | PR Newswire (US) | Nastech Receives Notice of Allowance for U.S. Patent Related to Methods for Identifying Cell-Specific Targeting Peptides | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 07/01/2008 | 14:00 | PR Newswire (US) | Nastech Appoints Bruce R. York as Interim Chief Financial Officer | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |
| 20/12/2007 | 14:30 | PR Newswire (US) | Nastech Announces Promotion of Gordon Brandt, M.D. to President | NASDAQ:NSTK | Nastech Pharmaceutical Company (MM) |